Next Article in Journal / Special Issue
Exploring Dangerous Connections between Klebsiella pneumoniae Biofilms and Healthcare-Associated Infections
Previous Article in Journal / Special Issue
Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs—A Review
Pathogens 2014, 3(3), 704-719; doi:10.3390/pathogens3030704
Article

Iron and Acinetobacter baumannii Biofilm Formation

,
,
,
,
 and *
Department of Sciences, Roma Tre University, Viale Marconi 446, 00146 Rome, Italy
* Author to whom correspondence should be addressed.
Received: 10 July 2014 / Revised: 9 August 2014 / Accepted: 12 August 2014 / Published: 18 August 2014
(This article belongs to the Special Issue Biofilm-Based Nosocomial Infections)
View Full-Text   |   Download PDF [583 KB, 22 August 2014; original version 18 August 2014]   |   Browse Figures

Abstract

Acinetobacter baumannii is an emerging nosocomial pathogen, responsible for infection outbreaks worldwide. The pathogenicity of this bacterium is mainly due to its multidrug-resistance and ability to form biofilm on abiotic surfaces, which facilitate long-term persistence in the hospital setting. Given the crucial role of iron in A. baumannii nutrition and pathogenicity, iron metabolism has been considered as a possible target for chelation-based antibacterial chemotherapy. In this study, we investigated the effect of iron restriction on A. baumannii growth and biofilm formation using different iron chelators and culture conditions. We report substantial inter-strain variability and growth medium-dependence for biofilm formation by A. baumannii isolates from veterinary and clinical sources. Neither planktonic nor biofilm growth of A. baumannii was affected by exogenous chelators. Biofilm formation was either stimulated by iron or not responsive to iron in the majority of isolates tested, indicating that iron starvation is not sensed as an overall biofilm-inducing stimulus by A. baumannii. The impressive iron withholding capacity of this bacterium should be taken into account for future development of chelation-based antimicrobial and anti-biofilm therapies.
Keywords: Acinetobacter baumannii; biofilm; chelator; deferasirox; deferiprone; deferoxamine; dipyridyl; iron; transferrin Acinetobacter baumannii; biofilm; chelator; deferasirox; deferiprone; deferoxamine; dipyridyl; iron; transferrin
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Export to BibTeX |
EndNote


MDPI and ACS Style

Gentile, V.; Frangipani, E.; Bonchi, C.; Minandri, F.; Runci, F.; Visca, P. Iron and Acinetobacter baumannii Biofilm Formation. Pathogens 2014, 3, 704-719.

View more citation formats

Supplement

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
Pathogens EISSN 2076-0817 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert